STI-2401
/ Salus Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 06, 2026
STI-2401: A Toxin-Neutralizing Liposomal Vancomycin with Improved Pulmonary Biodistribution, Favorable PK/Safety, and Clinical Development Readiness
(IDWeek 2026)
- No abstract available
Clinical • Infectious Disease
1 to 1
Of
1
Go to page
1